BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35415945)

  • 1. Impact of cirrhosis on long-term survival outcomes of patients with intrahepatic cholangiocarcinoma.
    Wang J; Qiu Y; Yang Y; Shen S; Zhi M; Zhang B; Wang W
    Cancer Med; 2022 Oct; 11(19):3633-3642. PubMed ID: 35415945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of liver fibrosis score on prognosis after common therapies for intrahepatic cholangiocarcinoma: a propensity score matching analysis.
    Zhang JX; Li P; Chen Z; Lin H; Cai Z; Liao W; Pan Z
    BMC Cancer; 2020 Jun; 20(1):556. PubMed ID: 32539768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
    Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomic versus non-anatomic resection for early-stage intrahepatic cholangiocarcinoma: a propensity score matching and stabilized inverse probability of treatment weighting analysis.
    Ke Q; Wang L; Lin Z; Liu H; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Liu J; Zeng Y
    BMC Cancer; 2023 Sep; 23(1):850. PubMed ID: 37697239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cirrhosis in intrahepatic cholangiocarcinoma: prognostic importance and impact on survival.
    Thakral N; Gonzalez T; Nano O; Shin SH; Samuels S; Hussein A
    BMC Gastroenterol; 2023 May; 23(1):151. PubMed ID: 37179301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis.
    Tang Y; Wang L; Teng F; Zhang T; Zhao Y; Chen Z
    Int J Med Sci; 2021; 18(1):187-198. PubMed ID: 33390787
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival Benefit of Surgical Treatment for Elderly Patients with Intrahepatic Cholangiocarcinoma: A Retrospective Cohort Study in the SEER Database by Propensity Score Matching Analysis.
    Chen K; Yu H; Yang J; Bo Z; Jin C; Wu L; Wang Y; Chen G
    Curr Oncol; 2023 Feb; 30(3):2642-2652. PubMed ID: 36975414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study.
    Zhou YW; Li QF; Chen YY; Wang K; Pu D; Chen XR; Li CH; Jiang L; Wang Y; Li Q; Yang Y; Gou HF; Bi F; Liu JY; Chen Y; Qiu M
    Eur J Surg Oncol; 2022 Jul; 48(7):1559-1566. PubMed ID: 35115213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of Intrahepatic Cholangiocarcinoma Etiology on Recurrence and Prognosis after Curative-Intent Resection: a Multi-Institutional Study.
    Zhang XF; Chakedis J; Bagante F; Beal EW; Lv Y; Weiss M; Popescu I; Marques HP; Aldrighetti L; Maithel SK; Pulitano C; Bauer TW; Shen F; Poultsides GA; Soubrane O; Martel G; Groot Koerkamp B; Guglielmi A; Itaru E; Pawlik TM
    World J Surg; 2018 Mar; 42(3):849-857. PubMed ID: 28879598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary tumor resection improves survival in patients with multifocal intrahepatic cholangiocarcinoma based on a population study.
    Yin L; Zhao S; Zhu H; Ji G; Zhang X
    Sci Rep; 2021 Jun; 11(1):12166. PubMed ID: 34108604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of lymph node dissection on clinical outcomes of intrahepatic cholangiocarcinoma: Inverse probability of treatment weighting with survival analysis.
    Umeda Y; Mitsuhashi T; Kojima T; Satoh D; Sui K; Endo Y; Inagaki M; Oishi M; Yagi T; Fujiwara T
    J Hepatobiliary Pancreat Sci; 2022 Feb; 29(2):217-229. PubMed ID: 34473411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics and prognosis of early-onset cholangiocarcinoma: a population-based study.
    Gao F; Xu X; Sun Y
    Scand J Gastroenterol; 2024; 59(2):183-191. PubMed ID: 37921657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A novel nomogram for individualized preoperative prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma].
    Ma WH; Lei ZQ; Yu QS; Xiao QR; Tang HL; Si AF; Yang PH; Cheng ZJ
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):363-371. PubMed ID: 35272428
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection.
    Jeong S; Gao L; Tong Y; Xia L; Xu N; Sha M; Zhang J; Kong X; Gu J; Xia Q
    Can J Gastroenterol Hepatol; 2017; 2017():6543423. PubMed ID: 29259967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics of intrahepatic cholangiocarcinoma in patients with cirrhosis.
    Li YY; Chen DJ; Li XR; Tian BN; Liu WD; Liu G; Li H
    Hepatogastroenterology; 2011; 58(110-111):1787-90. PubMed ID: 21940350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes of combined hepatocellular-cholangiocarcinoma compared with intrahepatic cholangiocarcinoma: A SEER population-based cohort study.
    Yang Z; Shi G
    Cancer Med; 2022 Feb; 11(3):692-704. PubMed ID: 34862762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of a History of Different Other Cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
    Chai J; Kong J; Zhu K
    Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lymph node dissection and a new N-staging system for intrahepatic cholangiocarcinoma: a study from the SEER database.
    Hu H; Zhao H; Cai J
    J Int Med Res; 2021 Jun; 49(6):3000605211012209. PubMed ID: 34098769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]   [Full Text] [Related]  

  • 20. Postoperative adjuvant therapy following radical resection for intrahepatic cholangiocarcinoma: A multicenter retrospective study.
    Wang L; Deng M; Ke Q; Lou J; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Zheng Y; Li J; Cheng S; Zhou W; Zeng Y
    Cancer Med; 2020 Apr; 9(8):2674-2685. PubMed ID: 32072774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.